Dr. George Bakris talks with Dr. Rajiv Agarwal about new research comparing the effectiveness of beta-blockers vs ACE inhibitors at controlling blood pressure in patients on dialysis.

Dr. Weber interviews World Hypertension League President-Elect Dr. Lackland on the salt controversy. Is a shake-up of the food industry needed?

New guidelines suggest that asymptomatic hyponatremia doesn't really exist but that clinicians can identify and treat it if they know the warning signs. Dr. Jeffrey Berns discusses.

Dr. Neil Stone, lead author of the cholesterol guidelines, is feeling optimistic, given more informed discussions of their applicability and supporting data for the CV risk calculator.

A percentage of doctors have begun selling vitamins and nutritional supplements as an ancillary service that they offer. Bioethicist Art Caplan says this is not necessarily a good move.

Dr. Seth Bilazarian reflects on the negative results for renal denervation, and the need for alternatives to multiple drugs for severe hypertension.

Co-PI Dr. George Bakris shares his perspective on what went wrong with the SYMPLICITY HTN-3 trial, and where it leaves renal denervation.

What will physician and patient interactions look like in the near future? Medscape Editor-in-Chief Eric Topol, MD, talks about how technology is changing the practice of medicine.

Dr. Jeffrey Berns talks with Dr. Peter Reese about the benefits of conducting a trial with paid kidney donors to help sort out the ethical issues involved.

Drs. Donal O'Donoghue and Lynda Szczech discuss the new guidelines issued by the Canadian Society of Nephrology, which encourage an individualized approach to dialysis initiation.